Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
31 October 2024 | Story André Damons | Photo André Damons
Prof Gert van-Zyl
Prof Gert van Zyl, Dean of the Faculty of Health Sciences, welcomed guests at the official launch of the faculty’s new programmes, the Master of Public Health and PhD Public Health in the Division of Public Health.

What started seven years ago as a dream, came to fruition in October 2024, when the Faculty of Health Sciences at the University of the Free State (UFS) officially launched two new programmes, the Master of Public Health and PhD Public Health in the Division of Public Health (DPH).

In his welcome address, Prof Gert van Zyl, Dean of the Faculty of Health Sciences, said it is a significant milestone launching these particularly important programmes in the faculty. The launch took place on 24 October 2024 at the James Moroka Building on the Bloemfontein Campus. These programmes are dedicated to recognising and responding to complex national and global public health challenges through high-quality research, teaching and learning, and engaged scholarship.

Prof Bonang Mohale, UFS Chancellor, and Dr BE Mzangwa, Acting Deputy Director General of the Free State Department of Health and CEO of the Universitas Academic Hospital, were also in attendance, while Mr Ramphelane Morewane, Deputy Director General of HIV/AIDS, TB, Maternal and Child Health, in the National Department of Health, delivered a congratulatory message virtually.

Said Prof Van Zyl: “The vision of the public health dream in the faculty started with a small group of us having a discussion on taking public health forward. At that first meeting we already agreed on an action plan. We knew then if we kept true to this dream, we would have success, but this success would not be for us. It would be for the influence of the lives of many postgraduate students that will enrol in the programmes in this division and uplift themselves by getting a quality and relevant qualification. Ready to serve the bigger community.

“For those who are part of the vision of the public health dream, remember the dream and vision, continue with the collaborative efforts and spirit, remain committed to the dream and do everything that is needed to allow it to excel, and never forget the core values we embraced at the beginning when we started this dream,” said Prof Van Zyl.

Addressing public health challenges

Prof Anthea Rhoda, Acting UFS Vice-Chancellor and Principal, said in a video message that the launch marks a significant milestone symbolising the beginning of an academic endeavour aligned with Vision 130, which emphasises academic excellence, quality and impact.

“Today’s launch represents a crucial step in the Faculty of Health Sciences’ commitment to address public health challenges within our communities, nationally, as well as globally. It also represents a crucial step in the University of the Free State’s dedication to tackling public health challenges that are prevalent in our communities.

“The Division of Public Health aspires to be engaging, diversifying public health through innovative, global responsive research. Public health, as is common knowledge, is the study and practice of safeguarding and improving the well-being of individuals and community. It includes the promotion of healthy lifestyles, the prevention of diseases and efforts to control infectious illnesses,” said Prof Rhoda.

She said it should be remembered that public health encompasses more than a simple field of study, it’s a commitment to service, and a promise to make a positive impact in the world. She is confident that this new programme will contribute significantly to the academic prestige of the UFS and will be a source of innovative solutions to the complex health challenges of the times.

Programmes in high demand

According to Prof Joyce Tsoka-Gwegweni, Vice-Dean: Research, Transformation, and Marketing and Head of the DPH, they only enrolled the first cohort of students in the second semester of 2023.

“During that time, we enrolled six Master of Public Health students and 14 PhDs. This year we enrolled 26 students, 13 in each programme. Currently we have 46 students. 19 Masters’ of Public Health and 27 PhD students, of which 90% are black female students. We also have international students from Lesotho, Namibia and Kenya. The quality of our students is very high. They are already working in health-related institutions and most of them are in leadership positions.

“For the coming year, 2025, we have already received 224 applications for the Master of Public Health programme and 30 for the PhD. We can only accommodate 30. Our programmes are already in high demand nationally and on the continent. They address a range of public health topics of national and international importance,” said the Vice-Dean.

Prof Tsoka-Gwegweni said because of the quality of staff and the quality and relevance of the programmes, their multidisciplinary nature, sustainability, and responsiveness to local, national and global public health challenges, these programmes are contributing to the UFS vision of achieving academic excellence, quality and impact; maximum societal impact with sustainable relationships; and of achieving a diverse, inclusive equitable university.

Health and prevention are primary

Prof Geoffrey Setswe, the Managing Director of the Aurum Research Institute, delivered the keynote address, saying public health, unlike medicine and nursing is not about treating individual patients, but focuses on the maintenance of promotion of health at a population level. Health and prevention are primary. He also talked about the public health pathways and career options in this field.

The best-known elements of public health, he said, are health promotion, environmental health, surveillance, communicable disease prevention, communication, health equity, emergency preparedness, harm reduction and home visiting programmes.

“The South African public health system is rebuilding itself and working to enhance health and well-being by implementing the NHI that will enable access to high quality, people-centred and integrated health care for all South Africans. Public health training must have multisectoral applications for public health careers, specialisation and advanced education providing life experiences and related expertise for people with diverse origins and ethical motivations,” he said.

According to Prof Setswe, this model will help in the training of public health professionals to deal with the quadruple burden of communicable diseases (HIV, TB, sepsis), non-communicable diseases (cancers, diabetes, cardiovascular diseases), injuries from crime and violence (including GBV), and mental health (including depression, para-suicide, risk behaviour, harmful substance abuse) and maternal and child health. 

Click to view documentClick and watch the official launch below:

News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept